ENTRY       D11056                      Drug
NAME        Mirtazapine hydrate (JAN)
FORMULA     C17H19N3. xH2O
CLASS       Cardiovascular agent
             DG01466  Adrenergic receptor antagonist
              DG01465  alpha-Adrenergic receptor antagonist
               DG01460  alpha2-Adrenergic receptor antagonist
            Neuropsychiatric agent
             DG01729  Tetracyclic antidepressant
             DG03077  Noradrenergic and specific serotonergic antidepressant (NaSSA)
            Gastrointestinal agent
             DG01489  5-HT3-receptor antagonist
            Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: N06AX11
            Chemical structure group: DG02838
            Product (DG02838): D00563<JP/US>
EFFICACY    Antidepressant, Serotonin receptor antagonist
TARGET      HTR2 [HSA:3356 3357 3358] [KO:K04157]
            HTR3 [HSA:3359 9177 170572 200909 285242] [KO:K04819]
            ADRA2 [HSA:150 151 152] [KO:K04138 K04139 K04140]
  PATHWAY   hsa04080(150+151+152+3356+3357+3358)  Neuroactive ligand-receptor interaction
            hsa04726(170572+200909+285242+3356+3357+3358+3359+9177)  Serotonergic synapse
METABOLISM  Enzyme: CYP1A2 [HSA:1544], CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N06 PSYCHOANALEPTICS
               N06A ANTIDEPRESSANTS
                N06AX Other antidepressants
                 N06AX11 Mirtazapine
                  D11056  Mirtazapine hydrate (JAN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG01460  alpha2-Adrenergic receptor antagonist
                 DG02838  Mirtazapine
                  D11056  Mirtazapine hydrate
             Neuropsychiatric agent
              DG01729  Tetracyclic antidepressant
               DG02838  Mirtazapine
                D11056  Mirtazapine hydrate
              DG03077  Noradrenergic and specific serotonergic antidepressant (NaSSA)
               DG02838  Mirtazapine
                D11056  Mirtazapine hydrate
             Gastrointestinal agent
              DG01489  5-HT3-receptor antagonist
               DG02838  Mirtazapine
                D11056  Mirtazapine hydrate
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG02838  Mirtazapine
                D11056  Mirtazapine hydrate
              DG01644  CYP2D6 substrate
               DG02838  Mirtazapine
                D11056  Mirtazapine hydrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG02838  Mirtazapine
                 D11056  Mirtazapine hydrate
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA2
                 D11056  Mirtazapine hydrate (JAN)
               Serotonin
                HTR2
                 D11056  Mirtazapine hydrate (JAN)
             Ion channels
              Ligand-gated ion channels
               Serotonin
                HTR3
                 D11056  Mirtazapine hydrate (JAN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11056
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01465  alpha-Adrenergic receptor antagonist
                DG01460  alpha2-Adrenergic receptor antagonist
                 DG02838  Mirtazapine
             Neuropsychiatric agent
              DG01729  Tetracyclic antidepressant
               DG02838  Mirtazapine
              DG03077  Noradrenergic and specific serotonergic antidepressant (NaSSA)
               DG02838  Mirtazapine
             Gastrointestinal agent
              DG01489  5-HT3-receptor antagonist
               DG02838  Mirtazapine
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               DG02838  Mirtazapine
              DG01644  CYP2D6 substrate
               DG02838  Mirtazapine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG02838  Mirtazapine
DBLINKS     PubChem: 363669769
ATOM        21
            1   C1y C    17.9614  -15.9896
            2   N1y N    19.3701  -15.9896
            3   C8y C    20.2153  -14.9331
            4   C8y C    19.9336  -13.5244
            5   C8y C    17.1162  -14.9331
            6   C1x C    18.6657  -12.9609
            7   C8y C    17.3979  -13.5244
            8   C8x C    15.7779  -15.3557
            9   C8x C    14.7214  -14.3696
            10  C8x C    15.0031  -13.0314
            11  C8x C    16.3414  -12.6087
            12  C8x C    20.9197  -12.6087
            13  C8x C    22.2579  -13.0314
            14  C8x C    22.6101  -14.3696
            15  N5x N    21.5536  -15.2853
            16  C1x C    20.0744  -17.1870
            17  C1x C    19.3701  -18.4549
            18  N1y N    18.0318  -18.4549
            19  C1x C    17.2570  -17.2575
            20  C1a C    17.3275  -19.7227
            21  O0  O    24.8500  -18.7600
BOND        23
            1     3   4 1
            2     1   5 1
            3     4   6 1
            4     2   3 1
            5     5   7 2
            6     1   2 1
            7     6   7 1
            8     5   8 1
            9     8   9 2
            10    9  10 1
            11   10  11 2
            12    7  11 1
            13    4  12 2
            14   12  13 1
            15   13  14 2
            16   14  15 1
            17    3  15 2
            18    2  16 1
            19   16  17 1
            20   17  18 1
            21   18  19 1
            22    1  19 1
            23   18  20 1
BRACKET     1    22.7500  -19.5300   22.7500  -17.6400
            1    25.6200  -17.6400   25.6200  -19.5300
            1  x
  ORIGINAL  1   21
  REPEAT    1 
///
